BRD4 and cancer: Studies on the cancer field have described that BRD4 contributes to the recruitment of the positive transcription elongation factor b (P-TEFb) complex (heterodimer of CDK9 and cyclin T1, T2, or K) to the promoter region and activates RNA polymerase II-dependent (RNAPII) transcription.